Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014).
about
Survival outcomes for Australian women receiving trastuzumab for HER2-positive metastatic breast cancer following (neo)adjuvant trastuzumab: a national population-based observational study (2006-2014).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Survival outcomes for Australi ...... servational study (2006-2014).
@en
Survival outcomes for Australi ...... static breast cancer following
@nl
type
label
Survival outcomes for Australi ...... servational study (2006-2014).
@en
Survival outcomes for Australi ...... static breast cancer following
@nl
prefLabel
Survival outcomes for Australi ...... servational study (2006-2014).
@en
Survival outcomes for Australi ...... static breast cancer following
@nl
P2093
P2860
P50
P356
P1476
Survival outcomes for Australi ...... servational study (2006-2014).
@en
P2093
Belinda E Kiely
Benjamin Daniels
Christine Y Lu
Sallie-Anne Pearson
Timothy Dobbins
P2860
P2888
P356
10.1038/BJC.2017.405
P407
P577
2017-11-14T00:00:00Z